Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy

Background: Abnormal redox equilibrium is a major contributor to tumor malignancy and treatment resistance. Understanding reactive oxygen species (ROS) metabolism is a key to clarify the tumor redox status. However, we have limited methods to evaluate ROS in tumor tissues and little knowledge on ROS...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Shuai, Yan, Zihao, Wu, Jianqi, Liu, Xing, Guan, Gefei, Zou, Cunyi, Guo, Qing, Zhu, Chen, Liu, Tianqi, Chen, Chen, Chen, Ling, Cheng, Peng, Cheng, Wen, Wu, Anhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606976/
https://www.ncbi.nlm.nih.gov/pubmed/33194713
http://dx.doi.org/10.3389/fonc.2020.581197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606976/
https://www.ncbi.nlm.nih.gov/pubmed/33194713
http://dx.doi.org/10.3389/fonc.2020.581197

Ejemplares similares